Advanced Prostate Cancer: Understanding ctDNA Tumor Fraction: A Pioneers in Practice Webinar

4 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
In this educational webinar, Dr. Jahan Aghalar reviews what ctDNA tumor fraction is and how it can help inform clinical decision-making in advanced prostate cancer. He reviews the benefits and limitations of tissue and liquid biopsy based CGP, defines what ctDNA tumor fraction is, how ctDNA tumor fraction is reported and lastly how it can impact clinical decision-making with uninformative negative liquid biopsy results.
Category
Oncology
Be the first to comment

Up Next